Incyte (INCY) Revenue — Quarter Ended Mar 31, 2026
Revenue for the quarter decreased sequentially but increased compared to the same quarter last year. The sequential decline reversed the prior upward trend, while the year-over-year gain indicates continued growth.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue for the quarter decreased sequentially but increased compared to the same quarter last year. The sequential decline reversed the prior upward trend, while the year-over-year gain indicates continued growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
-15.5%
Change from the immediately preceding quarter.
Year-over-year
+20.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $1.2B | +16.5% |
| Sep 30, 2025 | $1.4B | +20.0% |
| Dec 31, 2025 | $1.5B | +27.8% |
| Mar 31, 2026 | $1.3B | +20.9% |
Revenue performance
Revenue declined from the immediately preceding quarter, marking a reversal from the upward trajectory seen in the prior three quarters. The year-over-year comparison, however, showed a solid increase.
Quarterly comparison
Compared to the prior quarter, revenue fell, while relative to the same quarter one year earlier, revenue rose. The trailing twelve-month revenue reached a new high.
What to watch
The filing discusses generic competition for JAKAFI, which is a factor to monitor in future periods.